VP of Business Development, BioSim

Essential Skills & Experience:

• 15+ years of experience in biopharma or biotech business development or strategic transactions, demonstrating the ability to navigate high-stakes, multi-stakeholder negotiation environments. Experience selling Saas and consulting services a plus
• Demonstrated success managing sales of specialty products across multiple market segments. Have built an organization inclusive of existing accounts and net new deals.
• Proven track record overseeing the full customer experience, including field sales, technical service, application support, and customer care. Experience in pricing value-based engagements inclusive of joint development, consulting and product.
• An extensive, pre-existing professional network of senior-level contacts (Chief Technology Officers, Heads of Innovation, Heads of R&D) across the global biopharma industry, with a proven ability to initiate strategic conversations from scratch.
• A documented track record of personally leading and closing complex biopharma technology deals with $20M+ upfront and milestones exceeding $100M.
• Expert-level proficiency in deal qualification and pipeline management, leveraging data-driven insights to align commercial activities with overall enterprise strategy.
• Demonstrated leadership in an entrepreneurial or high-growth environment, with the ability to lead a team through ambiguity and make decisive strategic choices.

Highly Desired Skills & Experience:

• Significant industry influence, with previous deal successes featured in major publications like FiercePharma or FierceBiotech.
• Scientific fluency that allows for seamless communication with both research scientists and C-suite business leaders to bridge technical capabilities with commercial value.
• Experience leading commercial transformation or building high-performance commercial functions from the ground up.
• Advanced proficiency in leveraging CRM systems (Salesforce) to optimize customer management and revenue tracking.
• A history of managing large-scale, global accounts and navigating diverse value-chain partners in the tech-bio sector.
• Understanding of and fluency with the modern drug discovery landscape inclusive of data models and AI-based tools